Page last updated: 2024-09-03

sch 42495 and Ventricular Dysfunction, Left

sch 42495 has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Espiner, EA; Lainchbury, JG; Nicholls, MG; Richards, AM; Yandle, TG1

Trials

1 trial(s) available for sch 42495 and Ventricular Dysfunction, Left

ArticleYear
Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:2

    Topics: Adult; Aged; Aldosterone; Blood Pressure; Cyclic GMP; Drug Synergism; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Neprilysin; Protease Inhibitors; Renin; Ventricular Dysfunction, Left

1999